Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2015
Price : $35 *
At a glance
- Drugs BP 14979 (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Sponsors Bioprojet
- 20 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 09 Sep 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 09 Apr 2014 New source identified and integrated (European Clinical Trials Database).